ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 67 filers reported holding ADAMAS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $19,640,000 | -3.5% | 4,000,000 | +3.7% | 0.33% | -8.5% |
| Q2 2021 | $20,360,000 | +10.0% | 3,856,000 | 0.0% | 0.36% | -14.4% |
| Q1 2021 | $18,509,000 | +55.9% | 3,856,000 | +40.6% | 0.42% | +5.2% |
| Q4 2020 | $11,873,000 | +5.1% | 2,742,000 | 0.0% | 0.40% | -1.5% |
| Q3 2020 | $11,297,000 | +60.9% | 2,742,000 | 0.0% | 0.41% | +33.1% |
| Q2 2020 | $7,020,000 | -11.4% | 2,742,000 | 0.0% | 0.31% | -37.1% |
| Q1 2020 | $7,924,000 | -4.8% | 2,742,000 | +24.9% | 0.49% | +2.1% |
| Q4 2019 | $8,323,000 | +203.5% | 2,196,000 | +309.7% | 0.48% | +163.7% |
| Q3 2019 | $2,742,000 | -83.6% | 536,000 | -80.1% | 0.18% | -82.7% |
| Q2 2019 | $16,740,000 | -14.2% | 2,700,000 | -1.6% | 1.06% | -1.2% |
| Q1 2019 | $19,510,000 | +247.2% | 2,744,000 | +317.0% | 1.07% | +150.7% |
| Q4 2018 | $5,619,000 | -65.8% | 658,000 | -15.2% | 0.43% | -78.0% |
| Q3 2017 | $16,428,000 | -18.9% | 776,000 | -33.0% | 1.94% | -25.0% |
| Q2 2017 | $20,253,000 | +33.9% | 1,158,000 | +34.0% | 2.58% | -17.3% |
| Q1 2017 | $15,120,000 | +66.9% | 864,000 | +61.2% | 3.12% | +45.7% |
| Q4 2016 | $9,058,000 | – | 536,000 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|